ARCHIVES

NCI RFP Available.

This article is from The Cancer Letter archive.

Vol. 26 No. 07 | February 18, 2000

Download PDF Visit The Full Archive

Related Articles

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

HHS, NIH Prepare for Government Shutdown

September 20, 2013

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

Suspect Chemical Include Castor Oil, Witchhazel; Details On 38 Picked For Long Term Tests

August 5, 1977

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974

International Research Data Bank Up And Operating Through NLM Systems

September 20, 1974